ALEXANDER COLE-SELVAGGIO: Open Payments
NPI 1053737676 · WARREN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$872 in 37 payments from 12 companies in 2025. Trend: 2023 $605 · 2024 $690 · 2025 $872
Food & beverage: $872
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 15 | $372 |
| PFIZER INC. | 5 | $82 |
| Krystal Biotech Inc | 4 | $81 |
| Globus Medical, Inc. | 2 | $78 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| Novo Nordisk Inc | 2 | $43 |
| ABBVIE INC. | 2 | $41 |
| Merz Pharmaceuticals, LLC | 1 | $37 |
| Medtronic, Inc. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
Products named: INGREZZA, NURTEC ODT, VYJUVEK, Symbravo, Senza, Xeomin, OMNIA, QULIPTA.
Industry payments across MI — which companies pay providers there.
